{"id":"W4403623250","doi":"10.1093/bjd/ljae406","title":"Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Discontinuation; Internal medicine; Psoriasis Area and Severity Index; Adverse effect; Psoriasis; Placebo; Plaque psoriasis; Randomized controlled trial; Clinical trial; Gastroenterology; Dermatology; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001961772,0.001157554,0.001778345,0.0002946103,0.0005015612,0.0007471933,0.0005365936,0.0009401441,0.002978379],"category_scores_gemma":[0.0008998617,0.0004789376,0.001756391,0.0004033066,0.0006952947,0.0005533311,0.0002941357,0.001820212,0.000415489],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009932554,"about_ca_system_score_gemma":0.002294072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001768529,"about_ca_topic_score_gemma":0.005766097,"domain_scores_codex":[0.999518,0.0002084599,0.00004342182,0.00008799994,0.00004119293,0.0001009357],"domain_scores_gemma":[0.9993145,0.00008806647,0.0001468942,0.0000420836,0.0000583293,0.000350082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9152724,0.01680918,0.01347002,0.0009517294,0.002829517,0.0002004268,0.0002360895,0.0007906564,0.01059394,0.0001087825,0.002536739,0.03620056],"study_design_scores_gemma":[0.871573,0.09933346,0.02444268,0.00004346431,0.001297841,0.000198641,0.00008217002,0.0007057055,0.0009145358,0.00008106748,0.001300233,0.00002717277],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950906,0.001878002,0.0001305771,0.0003098549,0.00008110669,0.001317966,0.0003758947,0.0000297462,0.0007861056],"genre_scores_gemma":[0.9943434,0.001141584,0.0003563771,0.0006636656,0.00009041466,0.001610369,0.0008227635,0.000006674364,0.0009646153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002978379,"threshold_uncertainty_score":0.01037496,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01447980503829221,"score_gpt":0.2706572667441224,"score_spread":0.2561774617058302,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}